Literature DB >> 7613229

Antibiotic therapy for Listeria monocytogenes bacteremia.

C C Hung1, S C Chang, Y C Chen, W C Hsieh, K T Luh.   

Abstract

Listeria monocytogenes has been recognized as an important pathogen in immunocompromised patients, but it has been rarely reported in Taiwan. We reviewed 13 cases of L. monocytogenes bacteremia at National Taiwan University Hospital over a 12-year period. All of the patients had underlying diseases. Fever was the most common presenting symptom, and neurologic signs were found in 6 patients. Most of the patients received penicillin G, ampicillin or piperacillin with an aminoglycoside. Corticosteroids were used in 9 of 13 patients. The overall mortality directly due to L. monocytogenes bacteremia was 31%. However, patients treated with cephalosporins or oxacillin had higher mortality than those treated with penicillin G, ampicillin or piperacillin (p = 0.05). Given the increasing number of immunosuppressed patients in Taiwan, it is likely that more cases will be encountered. Physicians in Taiwan should be aware of L. monocytogenes bacteremia and its treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7613229

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  3 in total

1.  Daptomycin susceptibility of unusual gram-positive bacteria: comparison of results obtained by the Etest and the broth microdilution method.

Authors:  Yu-Tsung Huang; Chun-Hsing Liao; Lee-Jeng Teng; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

2.  Listeriosis, Taiwan, 1996-2008.

Authors:  Yu-Tsung Huang; Chun-Hsing Liao; Chia-Jui Yang; Lee-Jene Teng; Jin-Town Wang; Po-Ren Hsueh
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

3.  Emergence of sporadic non-clustered cases of hospital-associated listeriosis among immunocompromised adults in southern Taiwan from 1992 to 2013: effect of precipitating immunosuppressive agents.

Authors:  Chun-Yuan Lee; Hung-Chin Tsai; Calvin M Kunin; Susan Shin-Jung Lee; Kuan-Sheng Wu; Yao-Shen Chen
Journal:  BMC Infect Dis       Date:  2014-03-19       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.